SNN
$29.32+1.66%
as of close, Oct 20, 2026
☾ AH $29.32 +1.66%
Smith & Nephew SNATS Inc.Stock · Healthcare
SNN — Smith & Nephew SNATS Inc. price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeDDDDDDDDDDDDDDDDDDDD
25.030.035.040.045.0010.0M$29.32—20162019202120242026
2026-10-20
Price$29.32
MA20$29.48
MA50$32.40
Vol4.7M
Key stats#
Price data
- Price
- $29.32
- YTD price return
- -10.64%
- YTD total return
- -8.20%
- Market cap
- 12.9B
- Enterprise value
- 12.4B
- Shares outstanding
- 438.9M
- 52W low
- $26.12
- 52W high
- $37.51
- From 52W high
- -21.83%
- From 52W low
- +12.25%
- 52W range
- 28%
- Beta
- 0.55
Volume
- Rel volume
- 0.64×
- 30D volume
- 1.3M
- 30D $ vol
- 34.7M
Fundamentals
- Sales (ttm)
- 6.2B
- Sales/share
- $14.05
- EPS (ttm)
- $1.43
- FCF (ttm)
- 852M
- FCF/share
- $1.94
- Book value/share
- $12.05
- Net margin
- 10.14%
- ROE
- 11.82%
- ROA
- 5.98%
- Current ratio
- 2.57
Growth (CAGR, ttm) · 10Y
- Sales
- +6.10%+5.73%+6.21%+2.89%
- Net income
- +51.74%+40.98%+6.89%+4.31%
- FCF
- +40.63%+97.83%+11.61%+2.40%
- Shares
- +0.00%+0.00%-0.16%-0.24%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- +52.38%+41.07%+6.94%+4.61%
- Sales/share
- +6.09%+5.73%+6.39%+3.14%
- FCF/share
- +40.62%+97.82%+11.79%+2.65%
- Book value/share
- +0.45%+0.19%+0.20%+3.17%
- Dividend/share
- +0.92%+0.30%+0.28%+2.20%
- Price
- -19.31%+9.35%-3.85%-0.48%
- Total return
- -17.11%+12.29%-1.20%+1.86%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 20.5×
- P/OI (ttm)
- 16.2×
- Fwd P/E
- 12.1×
- P/S (ttm)
- 2.1×
- P/B (mrq)
- 2.4×
- P/FCF (ttm)
- 15.1×
- EV/EBITDA (fy)
- 10.2×
- EV/Sales (ttm)
- 2.0×
- FCF yield (ttm)
- 6.62%
- Dividend yield (ttm)
- 2.71%
- Buyback yield (realized, 1y)
- -0.00%
- Shareholder yield (realized, 1y)
- 3.06%
- Buyback yield (cash, ttm)
- 3.90%
- Shareholder yield (cash, ttm)
- 6.47%
Vs own 10Y history
- P/E
- 14th
- P/OI
- 3rd
- P/S
- 12th
- P/B
- 26th
- P/FCF
- 2nd
Bar = where today’s multiple sits in SNN’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-20#
1D
+1.66%
5D
+5.24%
1M
+6.39%
3M
-3.65%
YTD
-10.64%
1Y
-19.30%
5Y
-17.80%
Recent filings#
No earnings release, press release or insider trade outside a 10b5-1 plan in the last 120 days.
All filings and insider trades →Financial statements
Open full SNN financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
